No title
Neuroblastoma (NBL) is the most common pediatric extracranial solid tumor and often manifests in the adrenal gland affecting the sympathetic nervous system. Despite many treatment alternatives, the risk of relapse remains, and the overall five-year survival is around 50 %. By downregulating major histocompatibility complex I (MHC-I), the NBL cells can evade the immune system affecting the function
